RE: RIN 0938–AU44 Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; Quality Programs and Medica

Brooks-LaSure, On behalf of the undersigned national coalition of individuals and organizations, I am writing to comment on the Centers for Medicare & Medicaid Services (CMS) proposed change to the FY 2022 Inpatient Prospective Payment System (IPPS) rule regarding the proposed removal of “Death Among Surgical Inpatients with Serious Treatable Complications” (PSI-4) from the Inpatient Quality Repor. [...] • PSI-4 is a powerful and important patient safety measure, and patient safety is one of the most significant death risks Medicare beneficiaries and the public will ever encounter. [...] Despite this, there are relatively few patient safety measures reported in the IQR or used in payment programs, especially considering the evidence of the risk faced by Medicare beneficiaries and the public at large. [...] mailto:info@leapfrog-group.org The Leapfrog Group – info@leapfrog-group.org – Comments on CMS IPPS FY 2022 Proposed Rule – Page 2 of 3 • Improvements to PSI-4 can occur while the current measure continues to be included in the IQR and is publicly reported. [...] On behalf of The Leapfrog Group, our Board, our members, and the undersigned coalition of individuals and organizations, we strongly urge CMS to retain PSI-4 in the IQR and in public reporting.